About this trial
This study examines the comparative effects of ELDOA and Spinal Mobilization with Leg Movement (SMWLM) on lumbar radiculopathy
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 30 -50 years
both male and female
Unilateral lumbar radiculopathy
Posteriolateral mild disc herniation on MRI
Disqualifiers
MRI findings indicating i. Spinal instability ii. Significant neuroforaminal stenosis iii. Structural abnormalities requiring surgical intervention (e.g., large disc herniation )
Diagnosed spinal conditions i. Lumbar spondylolisthesis ii. Lumbar spine fracture iii. Spinal stenosis iv. Spinal tumor v. Ankylosing spondylitis
History of previous spinal surgery Pregnancy
Trial design
Parallel
Treatments tested in this trial
ELDOA
Procedure/SurgeryParticipants will receive a four-week physiotherapy program with three sessions per week. Each session will heat application followed by supervised stretching and strengthening exercises. Participants in Group A will receive ELDOA in addition to standard physiotherapy. Each position will be sustained for at least one minute, with gradual progression to the full posture as flexibility and control improve.
Spinal Mobilization with Limb Movement - SMWLM
Procedure/SurgeryParticipants will receive a four-week physiotherapy program with three sessions per week. Each session will heat application followed by supervised stretching and strengthening exercises. Participants in Group B will receive spinal mobilization combined with limb movement along with standard physiotherapy. The technique will be repeated three times.
Treatment groups
Trial outcomes
Primary outcomes
Functional Disability
Measured by Oswestry Disability Index, a 10-item questionnaire with six response options per item.
Pain Intensity
Pain severity will be measured using the Visual Analog Scale ranging from 0 (no pain) to 10 (worst imaginable pain).
Lumbar Range of Motion
Lumbar spine range of motion will be assessed using a bubble inclinometer.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.